AstraZeneca's David Brennan - CEO Pay

AstraZeneca CEO David BrennanDavid Brennan - AstraZeneca

Total Compensation: $4.7M

Details: So much for those rumors that Brennan turned down a double-digit pay increase. The CEO's compensation bounced back from 2007's 19 percent drop, with his total 2008 salary of £2.51 million ($4.7 million) coming in at a 17 percent increase over 2007. Brennan's base salary dropped from 2007's $2 million to 1.8 million in 2008, but his bonus jumped from $2,016,000 to $2,425,000. He also received $406,000 in allowances, which included a car, relocation funds and cash for a vested performance share plan award.

AstraZeneca News:
AZ's Brennan sees "top-line" challenges ahead
AstraZeneca - Top 5 layoffs of 2008
AZ nabs more uses for Seroquel XR
AZ's Brennan tries to conceal Crestor glee
AZ's expanded China focus pays off

AstraZeneca's David Brennan - CEO Pay
Read more on

Suggested Articles

The second of AbbVie’s highly anticipated 2019 blockbuster candidates is here: Its crucial Humira follow-up, Rinvoq.

Bristol-Myers Squibb’s takeover of Celgene hasn’t always gone smoothly, but now a once-left-for-dead centerpiece of that deal is ready to launch.

Investors sued Novo Nordisk in Denmark, claiming it misled the public about trouble plaguing its insulin franchise—and demanding $1.75B in damages.